Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Errors In Hypothesis Tests01:14

Errors In Hypothesis Tests

4.5K
When performing a hypothesis test, there are four possible outcomes depending on the actual truth (or falseness) of the null hypothesis and the decision to reject or not.
4.5K
Accuracy and Errors in Hypothesis Testing01:13

Accuracy and Errors in Hypothesis Testing

282
Hypothesis testing is a fundamental statistical tool that begins with the assumption that the null hypothesis H0 is true. During this process, two types of errors can occur: Type I and Type II. A Type I error refers to the incorrect rejection of a true null hypothesis, while a Type II error involves the failure to reject a false null hypothesis.
In hypothesis testing, the probability of making a Type I error, denoted as α, is commonly set at 0.05. This significance level indicates a 5%...
282
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
Bonferroni Test01:10

Bonferroni Test

2.8K
The Bonferroni test is a statistical test named after Carlo Emilio Bonferroni, an Italian mathematician best known for Bonferroni inequalities. This statistical test is a type of multiple comparison test to determine which means are different than the rest. Bonferroni test can minimize the Type 1 error by reducing the significance level alpha, which otherwise increases with sample pairs.
The means of different samples are first paired in all possible combinations.
The null hypothesis of the...
2.8K
Types of Hypothesis Testing01:11

Types of Hypothesis Testing

26.8K
There are three types of hypothesis tests: right-tailed, left-tailed, and two-tailed.
When the null and alternative hypotheses are stated, it is observed that the null hypothesis is a neutral statement against which the alternative hypothesis is tested. The alternative hypothesis is a claim that instead has a certain direction. If the null hypothesis claims that p = 0.5, the alternative hypothesis would be an opposing statement to this and can be put either p > 0.5, p < 0.5, or p...
26.8K
Randomized Experiments01:13

Randomized Experiments

7.2K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
7.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety-Driven Response Adaptive Randomization: An Application in Noninferiority Oncology Trials.

Statistics in medicine·2026
Same author

Sotatercept reduces bone morphogenetic protein signaling in patients with pulmonary arterial hypertension.

Science translational medicine·2026
Same author

A burn-in(g) question: How long should an initial equal randomization stage be before Bayesian response-adaptive randomization?

Statistical methods in medical research·2026
Same author

Drug Development for Pulmonary Arterial Hypertension: Unleashing the Potential of Single-Patient Studies Using Continuous Monitoring.

Pulmonary circulation·2025
Same author

Implementing response-adaptive randomisation in stratified rare-disease trials: Design challenges and practical solutions.

Statistical methods in medical research·2025
Same author

Implementing response-adaptive designs when responses are missing: Impute or ignore?

Statistical methods in medical research·2025
Same journal

Fast penalized generalized estimating equations for large longitudinal functional datasets.

Biometrics·2026
Same journal

Causally-interpretable random-effects meta-analysis.

Biometrics·2026
Same journal

Statistical inference for mean function of partially observed functional time series.

Biometrics·2026
Same journal

Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's disease.

Biometrics·2026
Same journal

Finite mixtures of linear quantile regressions with concomitant variables: a solution to endogeneity in longitudinal data modeling.

Biometrics·2026
Same journal

Discussion on "INTACT: a method for integration of longitudinal physical activity data from multiple sources" by Jingru Zhang, Erjia Cui, Hongzhe Li, and Haochang Shou.

Biometrics·2026
See all related articles

Related Experiment Video

Updated: Sep 9, 2025

Errors as a Means of Reducing Impulsive Food Choice
07:07

Errors as a Means of Reducing Impulsive Food Choice

Published on: June 5, 2016

8.8K

Revisiting optimal allocations for binary responses: insights from considering type-I error rate control.

Lukas Pin1, Sofía S Villar1, William F Rosenberger2

  • 1MRC Biostatistics Unit, University of Cambridge, Robinson Way, Cambridge, CB2 0SR, United Kingdom.

Biometrics
|August 29, 2025
PubMed
Summary
This summary is machine-generated.

This study introduces new optimal allocation methods for clinical trials to control the type-I error rate. These methods improve patient outcomes by robustly managing statistical inflation in adaptive trial designs.

Keywords:
Neyman allocationRSHIR allocationWald testpatient benefitscore test

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K

Related Experiment Videos

Last Updated: Sep 9, 2025

Errors as a Means of Reducing Impulsive Food Choice
07:07

Errors as a Means of Reducing Impulsive Food Choice

Published on: June 5, 2016

8.8K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K

Area of Science:

  • Clinical Trial Design
  • Biostatistics
  • Statistical Inference

Background:

  • Response-adaptive designs can inflate the type-I error rate, a problem not well-documented.
  • Existing methods to reduce type-I error rate inflation in adaptive designs are not robust.

Purpose of the Study:

  • To develop novel optimal allocation proportions for response-adaptive designs that control type-I error rate inflation.
  • To address the limitations of existing methods for managing statistical inflation in clinical trials.

Main Methods:

  • Derived two optimal allocation proportions using the score test and finite sample estimators.
  • Incorporated robust statistical tests and estimators into the optimization problem formulation.
  • Evaluated designs through simulations using early phase and confirmatory trial data.

Main Results:

  • The proposed optimal allocation proportions effectively control type-I error rate inflation.
  • New designs offer substantial advantages in patient outcomes compared to existing methods.
  • The score test and finite sample estimators provide a more robust solution.

Conclusions:

  • The novel optimal proportion designs provide a robust method for controlling type-I error rates in adaptive trials.
  • These designs can lead to improved patient outcomes while maintaining statistical integrity.
  • The framework is adaptable to various outcome types and trial structures.